Shanghai Titan Scientific Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	-	985.98	1,051	1,390	675.95
Trading Asset Securities	-	40.26	-	-	11
Cash & Short-Term Investments	847.38	1,026	1,051	1,390	686.95
Cash Growth	-17.43%	-2.31%	-24.43%	102.36%	-21.40%
Accounts Receivable	-	834.19	871.02	705.77	594.01
Other Receivables	-	15.08	16.28	18.67	21.3
Receivables	-	849.27	887.29	724.44	615.31
Inventory	-	1,064	989.88	850.5	590.65
Other Current Assets	-	199.27	176.65	173.78	196.54
Total Current Assets	-	3,139	3,104	3,139	2,089
Property, Plant & Equipment	-	1,015	753.75	384.25	212.27
Long-Term Investments	-	106.45	103.24	78.66	47.58
Goodwill	-	152.62	100.74	100.74	100.74
Other Intangible Assets	-	209.93	191.57	192.5	87
Long-Term Deferred Tax Assets	-	27.19	25.22	15.37	10.69
Long-Term Deferred Charges	-	113.28	54.25	23.45	31.77
Other Long-Term Assets	-	85.04	55.19	37.8	13.85
Total Assets	-	4,849	4,388	3,972	2,593
Accounts Payable	-	198.3	165.05	153.52	155.53
Accrued Expenses	-	78.69	72.36	64.09	45.19
Short-Term Debt	-	984.57	728.38	509.11	341.18
Current Portion of Long-Term Debt	-	83.99	55.82	30.01	0.84
Current Portion of Leases	-	13.16	14.85	10.65	6.39
Current Income Taxes Payable	-	1.08	2.32	11.05	21.5
Current Unearned Revenue	-	55.64	72.65	73.5	76.52
Other Current Liabilities	-	40.92	32.56	36.71	201.31
Total Current Liabilities	-	1,456	1,144	888.65	848.45
Long-Term Debt	-	434.38	322.38	270.25	108.28
Long-Term Leases	-	25.52	34.51	23.87	8.11
Long-Term Unearned Revenue	-	17.24	22.01	16.44	2.39
Long-Term Deferred Tax Liabilities	-	14.49	15.25	5.73	4.69
Other Long-Term Liabilities	-	30	-	-	5.39
Total Liabilities	-	1,978	1,538	1,205	977.3
Common Stock	-	164.44	117.97	84.07	76.25
Additional Paid-In Capital	-	2,083	2,137	2,155	1,136
Retained Earnings	-	528.1	526.95	473.81	363.73
Comprehensive Income & Other	-	10.55	9.1	6.51	-0.18
Total Common Equity	2,792	2,786	2,791	2,720	1,576
Minority Interest	-	84.57	59.57	46.97	40.06
Shareholders' Equity	2,867	2,871	2,850	2,767	1,616
Total Liabilities & Equity	-	4,849	4,388	3,972	2,593
Total Debt	1,489	1,542	1,156	843.89	464.79
Net Cash (Debt)	-642.01	-515.37	-105.38	546.23	222.16
Net Cash Growth	-	-	-	145.87%	-67.67%
Net Cash Per Share	-3.94	-3.20	-0.64	3.53	1.49
Filing Date Shares Outstanding	164.44	164.44	165.16	164.78	149.45
Total Common Shares Outstanding	164.44	164.44	165.16	164.78	149.45
Working Capital	-	1,683	1,960	2,250	1,241
Book Value Per Share	16.98	16.94	16.90	16.51	10.55
Tangible Book Value	2,441	2,424	2,498	2,426	1,388
Tangible Book Value Per Share	14.85	14.74	15.13	14.73	9.29
Buildings	-	260.37	259.91	56.02	54.55
Machinery	-	308.26	218.58	114.22	90.82
Construction In Progress	-	561.88	330.12	254.89	113.47

Source: S&P Global Market Intelligence. Standard template. Financial Sources.